Compounds > topotecan
Page last updated: 2024-08-24

topotecan and Abdominal Neoplasms

topotecan has been researched along with Abdominal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Harrie, RP; Levin, AM; Owen, L1
Castellano, A; De Ioris, MA; De Pasquale, MD; De Vito, R; Donfrancesco, A; Garganese, MC; Ilari, I; Inserra, A; Jenkner, A; Locatelli, F; Natali, G; Ravà, L1

Other Studies

2 other study(ies) available for topotecan and Abdominal Neoplasms

ArticleYear
Recurrent Subconjunctival Hemorrhage in a Child With an Orbital Mass.
    JAMA ophthalmology, 2021, 01-01, Volume: 139, Issue:1

    Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Eye Hemorrhage; Female; Humans; Infant; Neuroblastoma; Orbital Neoplasms; Recurrence; Topotecan; Treatment Outcome; Ultrasonography

2021
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
    European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:4

    Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Mesna; Neuroblastoma; Pilot Projects; Risk Factors; Thoracic Neoplasms; Topotecan; Treatment Outcome

2011